Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qiagen
QGEN
|
+$210M |
| 2 |
Jefferies Financial Group
JEF
|
+$187M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$126M |
| 4 |
Trip.com Group
TCOM
|
+$93.6M |
| 5 |
TAL Education Group
TAL
|
+$85.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$416M |
| 2 |
QGENF
QIAGEN NV
QGENF
|
+$213M |
| 3 |
Amazon
AMZN
|
+$209M |
| 4 |
Stellantis
STLA
|
+$180M |
| 5 |
TripAdvisor
TRIP
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 36.34% |
| 2 | Communication Services | 17.69% |
| 3 | Healthcare | 14.09% |
| 4 | Technology | 9.35% |
| 5 | Financials | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
ResMed
RMD
$30.6B
| $355M | 0.52% |
4,939,074
-110,110
| -2% | -$7.61M |
|
52
Under Armour
UAA
$2.84B
| $352M | 0.51% |
17,820,791
+284,884
| +2% | +$6.64M |
|
53
Atlassian
TEAM
$25.6B
| $323M | 0.47% |
10,793,259
+682,668
| +7% | +$19.3M |
|
|
MON
54
DELISTED
Monsanto Co
MON
| $316M | 0.46% |
2,792,698
-62,478
| -2% | -$6.91M |
|
55
Ionis Pharmaceuticals
IONS
$8.6B
| $314M | 0.46% |
7,814,797
-600,359
| -7% | -$27M |
|
56
Mettler-Toledo International
MTD
$28.6B
| $306M | 0.45% |
639,613
+9,219
| +1% | +$4.21M |
|
57
Itaú Unibanco
ITUB
$93.2B
| $285M | 0.41% |
48,595,588
-827,373
| -2% | -$4.91M |
|
58
Cemex
CX
$17.1B
| $275M | 0.4% |
31,576,565
-465,371
| -1% | -$3.91M |
|
59
Copa Holdings
CPA
$5.76B
| $275M | 0.4% |
2,445,599
-32,992
| -1% | -$3.36M |
|
|
GRUB
60
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $271M | 0.39% |
4,121,500
+56,130
| +1% | +$4.14M |
|
|
JUNO
61
DELISTED
Juno Therapeutics, Inc.
JUNO
| $248M | 0.36% |
11,197,863
+135,908
| +1% | +$2.92M |
|
|
FNGN
62
DELISTED
Financial Engines, Inc.
FNGN
| $242M | 0.35% |
5,558,964
-177,837
| -3% | -$7.12M |
|
|
SRCL
63
DELISTED
Stericycle Inc
SRCL
| $227M | 0.33% |
2,738,000
-61,330
| -2% | -$4.93M |
|
64
Kirby Corp
KEX
$7.01B
| $223M | 0.32% |
3,156,535
-51,841
| -2% | -$3.54M |
|
65
DNOW Inc
DNOW
$2.58B
| $217M | 0.32% |
12,823,140
-369,305
| -3% | -$7.27M |
|
|
66
Qiagen
QGEN
$8.54B
| $209M | 0.3% |
+6,818,876
| New | +$210M |
|
|
ABMD
67
DELISTED
Abiomed Inc
ABMD
| $209M | 0.3% |
1,672,435
+1,084,264
| +184% | +$126M |
|
68
Howard Hughes
HHH
$3.81B
| $200M | 0.29% |
1,786,130
-48,259
| -3% | -$5.19M |
|
69
Credicorp
BAP
$31.8B
| $199M | 0.29% |
1,220,077
+283,387
| +30% | +$46.6M |
|
70
Interactive Brokers
IBKR
$39.2B
| $199M | 0.29% |
22,901,736
+904,780
| +4% | +$8.43M |
|
71
Restaurant Brands International
QSR
$25.7B
| $198M | 0.29% |
3,555,869
-53,638
| -1% | -$2.81M |
|
72
Myriad Genetics
MYGN
$270M
| $191M | 0.28% |
9,922,453
-237,305
| -2% | -$4.2M |
|
73
Alnylam Pharmaceuticals
ALNY
$27.5B
| $171M | 0.25% |
3,334,511
+16,489
| +0.5% | +$762K |
|
74
ICICI Bank
IBN
$108B
| $169M | 0.25% |
21,564,643
-791,353
| -4% | -$5.91M |
|
75
Banco Bradesco
BBD
$39.3B
| $160M | 0.23% |
30,213,733
+3,325,959
| +12% | +$17.6M |
|
Similar funds
Baillie Gifford & Co's Q1 2017 Portfolio in Review
As of Q1 2017, Baillie Gifford & Co held 211 positions worth $68.7B, up 13% from $60.8B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Baillie Gifford & Co's Q1 2017 filing shows 13 new, 53 increased, 100 reduced and 11 closed positions. Its largest new stake was Qiagen: 6,818,876 shares worth $209M. The largest sale was First Republic Bank, an estimated $416M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, up from 35% a quarter earlier, followed by Communication Services and Healthcare.
- Baillie Gifford & Co's largest Q1 2017 buy was Qiagen: 6,818,876 shares worth $209M.
- Baillie Gifford & Co added most to Jefferies Financial Group in Q1 2017, an estimated $187M increase.
- Baillie Gifford & Co's biggest Q1 2017 reduction was First Republic Bank, cutting an estimated $416M.
- Baillie Gifford & Co fully exited QIAGEN NV in Q1 2017, selling an estimated $213M.
- Baillie Gifford & Co's ten largest holdings make up 50% of its $68.7B portfolio in Q1 2017.
- Baillie Gifford & Co opened 13 new positions and closed 11 in Q1 2017.
- Baillie Gifford & Co's portfolio value rose 13% quarter-over-quarter to $68.7B.
Based on Baillie Gifford & Co's 13F filing for Q1 2017, filed 12 May 2017.